Teprotumumab

Teprotumumab is an IGF-1 receptor (IGF-1R) blocking human monoclonal antibody. Teprotumumab binds to the ligand binding extracellular α-subunit domain of IGF-1R. Teprotumumab inhibits TSH and IGF-1 action in fibrocytes. Teprotumumab attenuates TSH-dependent IL-6 and IL-8 expression and Akt phosphorylation. Teprotumumab can be used for thyroid-associated ophthalmopathy research.
Read more
€0.00 (tax incl.)
Reference:
HY-P99165
Product Details
HY-P99165

Data sheet

Size
Multiple sizes
Reactivity
IGF-1R; TSH Receptor
Application
Metabolism-protein/nucleotide metabolism
CAS
1036734-93-6

Menu

Settings